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EDITORIAL 
Ultraviolet Radiation Produces Selective Immune Incompetence 
Ultraviolet radiation (UVR) from within spectrum B (UVB) 
has the recognized capacity to produce cutaneous malignancies 
in both humans and laboratory animals [1]. Epidemiologic 
evidence demonstrates convincingly that UVR from natural 
sunlight is responsible for the vast majority of human skin 
cancers. Because of this important clinical impact of UVR and 
because of the utility of UVB-induced tumors for laboratory 
models of carcinogenesis, considerable experimental effort has 
been directed in recent decades toward dissecting those patho-
genic mechanisms that are responsible for this effect. Primary 
emphasis in this work has been directed toward the hypothesis 
that DNA within epidermal cells is the relevant UVR photo-
receptor. More recently, however, a developing literature has 
come to document a different effect of UVB on cutaneous 
homeostasis. UVB exposure to skin is now known to produce 
selective immune incompetence. This incompetence has been 
demonstrated for the recognition of UVR-induced cutaneous 
malignancies and for the recognition of chemical sensitizers 
which reach cutaneous immunocompetent cells near to the time 
of irradiation. These observations provide strong circumstantial 
evidence that selective immune incompetence contributes sub-
stantially to the development of skin cancers. 
Concern for UVR-induced damage in humans has been em-
phasized greatly since 1974 by the successful use of photochem-
otherapy in treating psoriasis [2]. High doses of UVR in spec-
trum A (UVA), plus systemic psoralens as a chemical photo-
sensitizer (PUV A) have provided substantial benefit for many 
patients. In fact, UVB radiation was used to treat psoriasis for 
many decades although the possibility that carcinogenesis 
might be a significant hazard was largely discounted [3]. Since 
the introduction of PUVA therapy in 1974, however, there has 
been considerable attention directed to the possibility that 
psoralen photochemotherapy might lead to a delayed epidemic 
of cutaneous malignancies among treated patients, and a con-
siderable effort has been directed toward determining whether 
PUV A might produce immune incompetence similar to that 
which follows UVB irradiation. The report by Kripke, Morison, 
and Parrish in this issue of the Journal documents convincingly 
that exposure of murine skin to high doses of UV A radiation in 
the presence of 8-methoxypsoralen has the capacity to induce 
immunologic incompetence which is indistinguishable from that 
which follows UVB irradiation. 
Studies that identify the capacity of UVB to inhibit immune 
recognition in skin have two independent origins, one beginning 
with the examination of UVR-induced defects that accompany 
carcinogenesis, the other with UVB effects on epidermal Lan-
gerhans cells. This former area developed from the work of 
Kripke and her associates [5] and from the work of Daynes and 
his associates [6]. In independent studies with mice, both ob-
served that UVB exposure of skin in doses high enough to 
produce skin necrosis had two separable effects. First, as ex-
pected, it led to the development of cutaneous neoplasms. 
Secondly, UVB exposure led to the generation ofT lymphocytes 
which selectively suppressed immune recognition of UVR-in-
duced cutaneous tumor implants·. These suppressor T cells 
arose prior to the clinical appearance of malignancies in irra-
diated mice; they could be adoptively transferred to genetically 
identical naive recipients, and they demonstrated specificity by 
failing to influence the growth of chemically induced cutaneous 
tumors. In subsequent studies with grafts of irradiated skin it 
has been demonstrated in elegant fashion that these suppressor 
T lymphocytes will enhance the development of primary skin 
cancers as well [7]. Thus, relatively high doses ofUVB delivered 
chronically will generate suppressor T lymphocytes which spe-
cifically prevent the immune recognition and destruction of 
UVR-induced cutaneous tumors. One hypothesis that emerges 
from this observation is that tumor-promoting effects of UVB 
may be partially attributable to this selective immune incom-
petence. 
During the course of this work Kripke and her associates 
established a new line of investigation to determine whether 
UVB-induced immune incompetence was limited to tumor rec-
ognition. Working again with relatively high doses of UVB, 
they determined that mice treated in this way would develop 
several systemic antigen-presenting defects, defects which were 
once again independent of the site of irradiation. When mice 
were exposed to UVB on shaved dorsal surface skin, supsequent 
immunization through unirradiated ventral abdominal wall skin 
with trinitrochlorobenzene (TNCB) resulted in specific immune 
unresponsiveness to TNCB. This systemic effect of UVB was 
subsequently demonstrated to be attributable at least in part 
to the generation of antigen-specific suppressor T lymphocytes 
which would suppress the acquisition of immune reactivity to 
TNCB after adoptive transfer to naive recipients [8]. Green et 
al [9] and Fox et al [10] then demonstrated that UVB delivered 
in similar fashion would prevent effective antigen presentation 
by haptenated splenic adherent cells, confirming the systemic 
nature of this effect. Thus, relatively high doses of UVB could 
induce, on a systemic basis, an antigen-presenting defect which 
would result in at least three different defects: immune incom-
petence for tumor destruction and for hapten recognition in 
vivo and in vitro. 
Working from a different vantage point, immunologists and 
dermatologists were drawn 10 years ago to a new area of 
cutaneous biology. This attention was stimulated by Silber-
berg's histologic demonstration that lymphocytes would asso-
ciate preferentially with epidermal Langerhans cells in contact 
hypersensitivity reactions [11]. Subsequently, an enormous ar-
ray of studies has strongly substantiated the hypothesis that 
dendritic epidermal Langerhans cells perform antigen-present-
ing accessory cell functions within skin in a manner resembling 
that of antigen-presenting macrophages. Langerhans cells, as 
bone marrow-derived cells [12,13], exclusively within the epi-
dermis bear unique surface proteins and surface receptors usu-
ally found on cells of macrophage/ monocyte lineage. In terms 
of function, disaggregated suspensions of epidermal cells en-
riched for Langerhans cells, have been shown to substitute 
effectively for macrophages by inducing proliferative responses 
in primed T lymphocytes after exposure to appropriate antigens 
[14]. These and related observations have given rise to the 
hypothesis that Langerhans cells are responsible for antigen 
presentation during the acquisition of contact hypersensitivity. 
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A corollary of that hypothesis is that the distortion of Lan-
gerhans cell function or that conducting immunizing procedures 
through skin sites deficient in Langerhans cells should produce 
differing immune responses and in this way characterize their 
in vivo role. Working·with C57BL/6 mice, we initiated studies 
to test the possibility that UVB irradiation might distort anti-
gen presentation in vivo, perhaps by selectively inhibiting Lan-
gerhans cell function within skin [15]. When the reactive hapten 
dinitrofluorobenzene (DNFB) was painted on skin sites previ-
ously treated with relatively small quantities of UVB, and in 
86 EDITORIAL 
the absence of skin necrosis, immunization failed to occur. 
Moreover, this incompetence at immune recognition in skin 
was associated with profound changes in Langerhans cell sur-
face markers. 
Even more important than the failure to respond positively 
to immunization through UVB-irradiated skin was the obser-
vation that mice treated in this way then became specifically 
unresponsive to immunization through normal skin. This un-
responsiveness was restricted to the original hapten and could 
be produced only by painting hapten directly on the irradiated 
site. We have subsequently demonstrated that this unrespon-
siveness may be adoptively transferred to naive recipient mice 
with T lymphocytes [16]. Credence to the postulate that Lan-
gerhans cells contribute to this local and specific effect of UVB 
was given by two additional observations. Sauder et al [17] 
demonstrated that the capacity of derivatized epidermal cells 
to induce CH when injected subcutaneously could be inhibited 
substantially by prior treatment with UVB, and Sting! et al [18] 
demonstrated in vitro that UVB inhibits epidermal cells from 
presenting antigen to sensitized T lymphocytes. This capacity 
of UVB locally to produce immune incompetence contrasts in 
two major ways with studies derived from the tumor system. 
First, the doses of UVB required t o produce it are substantially 
lower, and secondly, the capacity to produce incompetence is 
limited strictly to the site of irradiation. Taken together, these 
studies identify a previously unexpected capacity of UVB to 
induce a spectrum of immunologic change in skin, but with the 
common denominator of immune incompetence which is me-
diated by suppressor T lymphocytes. They demonstrate clearly 
that immune recognition of foreign antigens may be severely 
and perhaps even permanently compromised, extending from 
tumor antigens to reactive haptens. They also provide a back-
ground for hypotheses concerning mechanisms by which UVB 
irradiation leads to cutaneous neoplasia. Immune incompetence 
expressed as failure to recognize novel antigens such as DNFB 
or perhaps tumor antigens will develop where antigen presen-
tation is distorted by UVB irradiation. We are intrigued by the 
observations that even low doses of UVB will induce a substan-
tial local immune defect, suggesting that UVB exposure from 
sunlight may promote tumor development by similar mecha-
nisms. This correlates with the clinical observation that basal 
cell carcinomas and squamous cell carcinomas arise predomi-
nantly in cutaneous sites that receive the most sun exposure. 
The work described in the report by Kripke, Morison, and 
Parrish evaluates the effect of PUV A on contact hypersensitiv-
ity in mice. In a manner similar to that observed for UVB, they 
observed selective immune incompetence for the recognition of 
reactive haptens painted on an unirradiated skin site. This 
important observation links closely the immunologic conse-
quences of UVB radiation with those of PUVA therapy. We 
can conclude thereby that the capacity of UVR to induce 
selective immune incompetence is not limited to the erythema 
spectrum. Furthermore, it serves as a reminder that PUV A 
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carcinogenesis remains a possible hazard for patients with pso-
riasis. 
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